These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 17121527

  • 21. Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes.
    Coppola G, Corrado E, Mulè MC, Augugliaro S, Cucchiara A, Novo G, Amoroso G, Assennato P, Hoffmann E, Vitale F, Novo S.
    Coron Artery Dis; 2009 May; 20(3):225-9. PubMed ID: 19387249
    [Abstract] [Full Text] [Related]

  • 22. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
    Arikan S, Tuzcu A, Gokalp D, Bahceci M, Danis R.
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
    [Abstract] [Full Text] [Related]

  • 23. Association of N-terminal pro B-type natriuretic peptide and sex hormone-binding globulin in non-obese peri- and postmenopausal women.
    Yasui T, Matsui S, Saijo A, Kaji T, Yamamoto S, Uemura H, Matsuzaki T, Irahara M.
    Clin Chim Acta; 2010 Feb; 411(3-4):280-4. PubMed ID: 19945451
    [Abstract] [Full Text] [Related]

  • 24. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
    van Gestel YR, Goei D, Hoeks SE, Sin DD, Flu WJ, Stam H, Mertens FW, Bax JJ, van Domburg RT, Poldermans D.
    COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
    [Abstract] [Full Text] [Related]

  • 25. Plasma N-terminal protype-B natriuretic peptide levels in risk assessment of patients with mitral regurgitation secondary to ischemic and nonischemic dilated cardiomyopathy.
    Dini FL, Fontanive P, Conti U, Andreini D, Cabani E, De Tommasi SM.
    Am Heart J; 2008 Jun; 155(6):1121-7. PubMed ID: 18513528
    [Abstract] [Full Text] [Related]

  • 26. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D, Flu WJ, Hoeks SE, Galal W, Dunkelgrun M, Boersma E, Kuijper R, van Kuijk JP, Winkel TA, Schouten O, Bax JJ, Poldermans D.
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [Abstract] [Full Text] [Related]

  • 27. Can pro-brain natriuretic peptide be used as a noninvasive predictor of elevated left ventricular diastolic pressures in patients with normal systolic function?
    Joung B, Ha JW, Ko YG, Kang SM, Rim SJ, Jang Y, Chung N, Shim WH, Cho SY.
    Am Heart J; 2005 Dec; 150(6):1213-9. PubMed ID: 16338261
    [Abstract] [Full Text] [Related]

  • 28. [Change of N-terminal pro-brain natriuretic peptide and big endothelin in patients undergoing coronary artery bypass grafting].
    Lu YF, Qi HW, Tang CZ, Wu MY, Wang Y, Zhao FH.
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Nov; 19(11):667-70. PubMed ID: 17996134
    [Abstract] [Full Text] [Related]

  • 29. Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes.
    Tildesley HD, Aydin CM, Ignaszewski A, Strelzow JA, Yu E, Bondy G.
    Int J Cardiol; 2007 Feb 14; 115(3):312-7. PubMed ID: 16824633
    [Abstract] [Full Text] [Related]

  • 30. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 31. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K, Yavavli A, Apak I, Ariturk Z, Toprak N.
    Am Heart J; 2006 May 23; 151(5):1115-22. PubMed ID: 16644347
    [Abstract] [Full Text] [Related]

  • 32. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M.
    J Cardiovasc Med (Hagerstown); 2009 Mar 23; 10(3):238-44. PubMed ID: 19262210
    [Abstract] [Full Text] [Related]

  • 33. Effect of azotemia on serum N-terminal proBNP concentration in dogs with normal cardiac function: a pilot study.
    Schmidt MK, Reynolds CA, Estrada AH, Prosek R, Maisenbacher HW, Sleeper MM, Oyama MA.
    J Vet Cardiol; 2009 May 23; 11 Suppl 1():S81-6. PubMed ID: 19394913
    [Abstract] [Full Text] [Related]

  • 34. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
    Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, Moschella S, Psaroudaki M, Del Forno D, Orio F, Vitale DF, Chiariello M, Vigorito C.
    Eur J Cardiovasc Prev Rehabil; 2008 Feb 23; 15(1):113-8. PubMed ID: 18277196
    [Abstract] [Full Text] [Related]

  • 35. N-terminal pro-B-type natriuretic peptide is associated with adverse short-term clinical outcomes in patients with acute ST-elevation myocardial infarction underwent primary percutaneous coronary intervention.
    Kwon TG, Bae JH, Jeong MH, Kim YJ, Hur SH, Seong IW, Cho MC, Seung KB, Jang YS, Park SJ, Korea Acute Myocardial Infarction Registry Investigators.
    Int J Cardiol; 2009 Apr 03; 133(2):173-8. PubMed ID: 18281115
    [Abstract] [Full Text] [Related]

  • 36. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.
    Kim JY, Lee EY, Jee JH, Lee BW, Chung JH, Jeun ES, Min YK, Lee MS, Kim KW, Lee MK.
    Diabetes Res Clin Pract; 2007 Sep 03; 77 Suppl 1():S238-42. PubMed ID: 17490778
    [Abstract] [Full Text] [Related]

  • 37. Head-to-head comparison of B-type natriuretic peptide (BNP) and NT-proBNP in daily clinical practice.
    Mair J, Gerda F, Renate H, Ulmer H, Andrea G, Pachinger O.
    Int J Cardiol; 2008 Feb 29; 124(2):244-6. PubMed ID: 17360054
    [Abstract] [Full Text] [Related]

  • 38. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW, Beede J, Isakson S, Villard-Saussine S, Fareh J, Clopton P, Fitzgerald RL, Maisel AS.
    J Am Coll Cardiol; 2008 May 13; 51(19):1874-82. PubMed ID: 18466803
    [Abstract] [Full Text] [Related]

  • 39. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D, Berger R, Struck J, Gleiss A, Hammer A, Morgenthaler NG, Bergmann A, Huelsmann M, Pacher R.
    J Am Coll Cardiol; 2009 May 12; 53(19):1783-90. PubMed ID: 19422985
    [Abstract] [Full Text] [Related]

  • 40. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
    Nguyen TH, Neil CJ, Sverdlov AL, Mahadavan G, Chirkov YY, Kucia AM, Stansborough J, Beltrame JF, Selvanayagam JB, Zeitz CJ, Struthers AD, Frenneaux MP, Horowitz JD.
    Am J Cardiol; 2011 Nov 01; 108(9):1316-21. PubMed ID: 21871590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.